Vericel Corporation VCEL
Updated: 16 Jun 2026
No signal published yet
We already track Vericel and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Vericel Corporation? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Vericel free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On May 7, 2026, Vericel reported first-quarter revenue growth of 30% to $68.4 million and raised its full-year 2026 financial guidance. The company also announced FDA approval for commercial manufacturing of MACI at its new facility in Burlington, Massachusetts. On June 16, 2026, Vericel is scheduled to present at the Truist Securities MedTech Conference.
What Firelda Watch includes for Vericel Corporation
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Vericel Corporation? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Vericel free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more